Cinven looks to take Synlab private as Covid boost falters

Frankfurt-listed Synlab could be about to be taken private following a non-binding full takeover offer earlier this week. With its full year results released yesterday and facing questions about its plans, HBI asks market experts what they think of the move.

Has the RAD-x sale stalled?

The sale process for pan-European radiology group RAD-x may have stalled, with no statements on progress from any of the parties involved. A well-placed German imaging operator tells HBI that the sale will no longer go ahead, while the group itself is giving nothing away.

Sanoptis targets Spain for expansion

Sanoptis, Germany’s second largest ophthalmology group by revenue, is looking to expand in Spain, and beyond, and looking at targets to buy.

EDG sale “in early stages”

HBI understands that the sale of pan-European and dentist-led European Dental Group (EDG) has begun, and is in its very early stages. 

Swiss Medical Network subsidiary to become country’s first payor-provider

Hôpital du Jura Bernois, a subsidiary of Switzerland's second largest hospital group Swiss Medical Network, is to become the country's first integrated payor-provider, after health insurer Visana bought a 32.4% stake. From January 1 2023 it will offer insurance alongside its hospital and outpatient services to inhabitants of the Jura Arc region.

EDG for sale, while Dentex sells

As exclusively predicted by HBI at the start of August, pan-European and dentist-led European Dental Group (EDG) is up for sale.

European Dental Group “up for sale soon”

HBI hears that pan-European and dentist-led European Dental Group (EDG) could be up for sale soon. HBI takes a look at the business and possible pricing at a time when dentistry continues to be a hot ticket.

Mediclinic accepts £3.7bn bid

The board of Mediclinic, the South Africa-based multinational hospital giant, have announced they have agreed acquisition terms with the consortium comprised of Remgro, the investment vehicle of the billionaire Rupert family and a long-time Mediclinic shareholder, and the Mediterranean Shipping Company (MSC). They have recommended these terms to shareholders.

Bid may undervalue Mediclinic

South African analysts say the 504p per share, £3.7bn proposed cash offer for Mediclinic International's equity, the South African, Swiss and Middle East hospital group may somewhat undervalue the business. The current offer equates to an enterprise value of £5.88bn. Analysts put the break up value on an enterprise value at between £5.5bn and £6.2bn. HBI reckons the equity alone could be worth £5.2bn.

Find Us